Phase I trial with pharmocokinetics, dosimetry, toxicity and response of anti-stromal therapy using I-131 labeled chimeric anti-tenascin therapy for lymphoma.


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Rizzieri, DA; Akabani, G; Zalutsky, M; Coleman, RE; Toaso, B; Anderson, E; Lagoo, A; Clayton, S; Niedzwiecki, D; Moore, JO; Gockerman, JP; DeCastro, C; Chao, NJ; Gasparetto, C; Bigner, DD

Published Date

  • November 16, 2003

Published In

Volume / Issue

  • 102 / 11

Start / End Page

  • 635A - 636A

Published By


  • 2

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 45th Annual Meeting of the American-Society-of-Hematology

Conference Location


Conference Start Date

  • December 6, 2003

Conference End Date

  • December 9, 2003